ABVC BioPharma, Inc. (ABVC) ownership: Top institutional holder: VANGUARD GROUP INC ($613306.00). Insider activity: Net Seller (4 buys, 16 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| VANGUARD GROUP INC | 287937.00 | $613306.00 | 2025-12-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 221169.00 | $214598.00 | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 190574.00 | $184857.00 | 2026-03-31 |
| CITADEL ADVISORS LLC | 55543.00 | $118307.00 | 2025-12-31 |
| VANGUARD FIDUCIARY TRUST CO | 97363.00 | $94442.00 | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 95100.00 | $92257.00 | 2026-03-31 |
| STATE STREET CORP | 72800.00 | $70623.00 | 2026-03-31 |
| BlackRock, Inc. | 56442.00 | $54754.00 | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2012-01-27 | |
| Sell | null | 2011-05-25 | |
| Sell | null | 2011-05-11 | |
| Sell | null | 2011-05-11 | |
| Sell | null | 2011-05-11 | |
| Sell | null | 2011-05-11 | |
| Sell | null | 2010-08-12 | |
| Sell | null | 2010-03-22 |
Back to ABVC overview · ABVC earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.